nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCB1—colon cancer	0.363	1	CbGaD
Rilpivirine—SLCO1B1—Irinotecan—colon cancer	0.0813	0.143	CbGbCtD
Rilpivirine—SLCO1B3—Methotrexate—colon cancer	0.0738	0.13	CbGbCtD
Rilpivirine—ABCG2—Irinotecan—colon cancer	0.0646	0.114	CbGbCtD
Rilpivirine—ABCG2—Fluorouracil—colon cancer	0.062	0.109	CbGbCtD
Rilpivirine—ABCG2—Vincristine—colon cancer	0.0564	0.0993	CbGbCtD
Rilpivirine—CYP2B6—Irinotecan—colon cancer	0.0454	0.0799	CbGbCtD
Rilpivirine—SLCO1B1—Methotrexate—colon cancer	0.043	0.0757	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—colon cancer	0.0342	0.0601	CbGbCtD
Rilpivirine—CYP1A2—Fluorouracil—colon cancer	0.0255	0.045	CbGbCtD
Rilpivirine—ABCB1—Irinotecan—colon cancer	0.0233	0.041	CbGbCtD
Rilpivirine—ABCB1—Vincristine—colon cancer	0.0203	0.0358	CbGbCtD
Rilpivirine—CYP3A4—Irinotecan—colon cancer	0.0139	0.0245	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—colon cancer	0.0123	0.0217	CbGbCtD
Rilpivirine—CYP3A4—Vincristine—colon cancer	0.0122	0.0215	CbGbCtD
Rilpivirine—Pazopanib—FGFR3—colon cancer	0.00615	0.746	CrCbGaD
Rilpivirine—Lipase increased—Irinotecan—colon cancer	0.00261	0.0693	CcSEcCtD
Rilpivirine—Etravirine—ABCB1—colon cancer	0.00146	0.177	CrCbGaD
Rilpivirine—NR1I2—digestive system—colon cancer	0.00142	0.132	CbGeAlD
Rilpivirine—Serum creatinine increased—Irinotecan—colon cancer	0.00125	0.0331	CcSEcCtD
Rilpivirine—Depressed mood—Capecitabine—colon cancer	0.00115	0.0305	CcSEcCtD
Rilpivirine—NR1I2—liver—colon cancer	0.00106	0.098	CbGeAlD
Rilpivirine—Opportunistic infection—Methotrexate—colon cancer	0.000947	0.0252	CcSEcCtD
Rilpivirine—NR1I2—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000893	0.072	CbGpPWpGaD
Rilpivirine—Platelet count decreased—Capecitabine—colon cancer	0.000862	0.0229	CcSEcCtD
Rilpivirine—Serum creatinine increased—Capecitabine—colon cancer	0.000833	0.0222	CcSEcCtD
Rilpivirine—ABCG2—Abacavir transmembrane transport—ABCB1—colon cancer	0.000825	0.0666	CbGpPWpGaD
Rilpivirine—Blood bilirubin increased—Irinotecan—colon cancer	0.00081	0.0215	CcSEcCtD
Rilpivirine—Inflammation—Fluorouracil—colon cancer	0.000756	0.0201	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—HNF4A—colon cancer	0.000751	0.0607	CbGpPWpGaD
Rilpivirine—Haemoglobin decreased—Capecitabine—colon cancer	0.000745	0.0198	CcSEcCtD
Rilpivirine—SLCO1B3—vagina—colon cancer	0.00072	0.0665	CbGeAlD
Rilpivirine—Hepatotoxicity—Capecitabine—colon cancer	0.000664	0.0176	CcSEcCtD
Rilpivirine—Pazopanib—ABCB1—colon cancer	0.000635	0.0771	CrCbGaD
Rilpivirine—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000612	0.0494	CbGpPWpGaD
Rilpivirine—SLCO1B3—liver—colon cancer	0.000607	0.0561	CbGeAlD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.000594	0.0479	CbGpPWpGaD
Rilpivirine—Renal impairment—Irinotecan—colon cancer	0.000584	0.0155	CcSEcCtD
Rilpivirine—SLCO1B1—renal system—colon cancer	0.000575	0.0531	CbGeAlD
Rilpivirine—Blood bilirubin increased—Capecitabine—colon cancer	0.000542	0.0144	CcSEcCtD
Rilpivirine—Inflammation—Capecitabine—colon cancer	0.000528	0.014	CcSEcCtD
Rilpivirine—Blood creatinine increased—Irinotecan—colon cancer	0.000521	0.0138	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000514	0.0137	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000513	0.0414	CbGpPWpGaD
Rilpivirine—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000501	0.0133	CcSEcCtD
Rilpivirine—Hepatotoxicity—Methotrexate—colon cancer	0.000494	0.0131	CcSEcCtD
Rilpivirine—ABCG2—Abacavir transport and metabolism—ABCB1—colon cancer	0.000474	0.0382	CbGpPWpGaD
Rilpivirine—SLCO1B1—digestive system—colon cancer	0.000471	0.0436	CbGeAlD
Rilpivirine—Depression—Vincristine—colon cancer	0.000439	0.0117	CcSEcCtD
Rilpivirine—Sleep disorder—Capecitabine—colon cancer	0.00043	0.0114	CcSEcCtD
Rilpivirine—Renal failure—Irinotecan—colon cancer	0.000421	0.0112	CcSEcCtD
Rilpivirine—Inflammation—Methotrexate—colon cancer	0.000393	0.0105	CcSEcCtD
Rilpivirine—Renal impairment—Capecitabine—colon cancer	0.000391	0.0104	CcSEcCtD
Rilpivirine—Urinary tract disorder—Vincristine—colon cancer	0.00039	0.0104	CcSEcCtD
Rilpivirine—Urethral disorder—Vincristine—colon cancer	0.000387	0.0103	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000357	0.0288	CbGpPWpGaD
Rilpivirine—SLCO1B1—liver—colon cancer	0.000351	0.0325	CbGeAlD
Rilpivirine—Blood creatinine increased—Capecitabine—colon cancer	0.000349	0.00927	CcSEcCtD
Rilpivirine—Immune system disorder—Irinotecan—colon cancer	0.000347	0.00923	CcSEcCtD
Rilpivirine—ABCB1—blood vessel—colon cancer	0.000347	0.0321	CbGeAlD
Rilpivirine—Mental disorder—Vincristine—colon cancer	0.000346	0.0092	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000335	0.00891	CcSEcCtD
Rilpivirine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000335	0.027	CbGpPWpGaD
Rilpivirine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000328	0.00872	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors—PPARG—colon cancer	0.000326	0.0263	CbGpPWpGaD
Rilpivirine—Abdominal discomfort—Capecitabine—colon cancer	0.000308	0.0082	CcSEcCtD
Rilpivirine—CYP2C19—digestive system—colon cancer	0.000307	0.0284	CbGeAlD
Rilpivirine—CYP1A2—renal system—colon cancer	0.000306	0.0283	CbGeAlD
Rilpivirine—CYP2B6—renal system—colon cancer	0.000293	0.0271	CbGeAlD
Rilpivirine—CYP2B6—Metapathway biotransformation—CHST4—colon cancer	0.00029	0.0234	CbGpPWpGaD
Rilpivirine—Depression—Capecitabine—colon cancer	0.000286	0.0076	CcSEcCtD
Rilpivirine—Renal failure—Capecitabine—colon cancer	0.000282	0.00749	CcSEcCtD
Rilpivirine—SLCO1B1—Irinotecan Pathway—APC—colon cancer	0.000282	0.0227	CbGpPWpGaD
Rilpivirine—Infection—Vincristine—colon cancer	0.000279	0.00741	CcSEcCtD
Rilpivirine—Nervous system disorder—Vincristine—colon cancer	0.000275	0.00731	CcSEcCtD
Rilpivirine—Infection—Irinotecan—colon cancer	0.000271	0.00722	CcSEcCtD
Rilpivirine—CYP2C19—vagina—colon cancer	0.000271	0.0251	CbGeAlD
Rilpivirine—Hepatobiliary disease—Capecitabine—colon cancer	0.000271	0.00721	CcSEcCtD
Rilpivirine—Nervous system disorder—Irinotecan—colon cancer	0.000268	0.00712	CcSEcCtD
Rilpivirine—ABCG2—Irinotecan Pathway—APC—colon cancer	0.000261	0.0211	CbGpPWpGaD
Rilpivirine—Infection—Fluorouracil—colon cancer	0.00026	0.00691	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000258	0.0208	CbGpPWpGaD
Rilpivirine—Nervous system disorder—Fluorouracil—colon cancer	0.000257	0.00682	CcSEcCtD
Rilpivirine—Urinary tract disorder—Capecitabine—colon cancer	0.000254	0.00676	CcSEcCtD
Rilpivirine—Insomnia—Vincristine—colon cancer	0.000254	0.00675	CcSEcCtD
Rilpivirine—Urethral disorder—Capecitabine—colon cancer	0.000252	0.00671	CcSEcCtD
Rilpivirine—CYP1A2—digestive system—colon cancer	0.000251	0.0232	CbGeAlD
Rilpivirine—Insomnia—Irinotecan—colon cancer	0.000247	0.00657	CcSEcCtD
Rilpivirine—Decreased appetite—Vincristine—colon cancer	0.000244	0.00648	CcSEcCtD
Rilpivirine—CYP2B6—lymphoid tissue—colon cancer	0.000243	0.0225	CbGeAlD
Rilpivirine—Somnolence—Irinotecan—colon cancer	0.000243	0.00646	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Vincristine—colon cancer	0.000242	0.00644	CcSEcCtD
Rilpivirine—Fatigue—Vincristine—colon cancer	0.000242	0.00643	CcSEcCtD
Rilpivirine—CYP2B6—digestive system—colon cancer	0.00024	0.0222	CbGeAlD
Rilpivirine—ABCG2—bone marrow—colon cancer	0.00024	0.0222	CbGeAlD
Rilpivirine—Decreased appetite—Irinotecan—colon cancer	0.000238	0.00631	CcSEcCtD
Rilpivirine—Insomnia—Fluorouracil—colon cancer	0.000237	0.00629	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000236	0.00627	CcSEcCtD
Rilpivirine—Fatigue—Irinotecan—colon cancer	0.000236	0.00626	CcSEcCtD
Rilpivirine—Somnolence—Fluorouracil—colon cancer	0.000233	0.00618	CcSEcCtD
Rilpivirine—Immune system disorder—Capecitabine—colon cancer	0.000232	0.00618	CcSEcCtD
Rilpivirine—ABCG2—vagina—colon cancer	0.00023	0.0213	CbGeAlD
Rilpivirine—Abdominal discomfort—Methotrexate—colon cancer	0.00023	0.0061	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Vincristine—colon cancer	0.000229	0.0061	CcSEcCtD
Rilpivirine—CYP2C19—liver—colon cancer	0.000229	0.0212	CbGeAlD
Rilpivirine—Decreased appetite—Fluorouracil—colon cancer	0.000227	0.00605	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000226	0.00601	CcSEcCtD
Rilpivirine—Mental disorder—Capecitabine—colon cancer	0.000226	0.00599	CcSEcCtD
Rilpivirine—Malnutrition—Capecitabine—colon cancer	0.000224	0.00596	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Irinotecan—colon cancer	0.000223	0.00594	CcSEcCtD
Rilpivirine—Abdominal pain—Vincristine—colon cancer	0.000222	0.0059	CcSEcCtD
Rilpivirine—CYP3A4—renal system—colon cancer	0.000221	0.0205	CbGeAlD
Rilpivirine—CYP2C19—Metapathway biotransformation—CHST4—colon cancer	0.000219	0.0177	CbGpPWpGaD
Rilpivirine—Abdominal pain—Irinotecan—colon cancer	0.000216	0.00574	CcSEcCtD
Rilpivirine—Depression—Methotrexate—colon cancer	0.000213	0.00566	CcSEcCtD
Rilpivirine—CYP2B6—vagina—colon cancer	0.000212	0.0196	CbGeAlD
Rilpivirine—Renal failure—Methotrexate—colon cancer	0.00021	0.00558	CcSEcCtD
Rilpivirine—ABCB1—embryo—colon cancer	0.000207	0.0191	CbGeAlD
Rilpivirine—Hepatobiliary disease—Methotrexate—colon cancer	0.000202	0.00537	CcSEcCtD
Rilpivirine—Asthenia—Vincristine—colon cancer	0.000201	0.00535	CcSEcCtD
Rilpivirine—Asthenia—Irinotecan—colon cancer	0.000196	0.00521	CcSEcCtD
Rilpivirine—ABCG2—liver—colon cancer	0.000194	0.0179	CbGeAlD
Rilpivirine—Diarrhoea—Vincristine—colon cancer	0.000192	0.0051	CcSEcCtD
Rilpivirine—Anxiety—Capecitabine—colon cancer	0.00019	0.00505	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000189	0.00504	CcSEcCtD
Rilpivirine—Urinary tract disorder—Methotrexate—colon cancer	0.000189	0.00503	CcSEcCtD
Rilpivirine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000189	0.0152	CbGpPWpGaD
Rilpivirine—Urethral disorder—Methotrexate—colon cancer	0.000188	0.00499	CcSEcCtD
Rilpivirine—Diarrhoea—Irinotecan—colon cancer	0.000187	0.00497	CcSEcCtD
Rilpivirine—CYP1A2—liver—colon cancer	0.000187	0.0173	CbGeAlD
Rilpivirine—Dry mouth—Capecitabine—colon cancer	0.000187	0.00496	CcSEcCtD
Rilpivirine—Dizziness—Vincristine—colon cancer	0.000186	0.00493	CcSEcCtD
Rilpivirine—Infection—Capecitabine—colon cancer	0.000182	0.00483	CcSEcCtD
Rilpivirine—CYP3A4—digestive system—colon cancer	0.000182	0.0168	CbGeAlD
Rilpivirine—Dizziness—Irinotecan—colon cancer	0.000181	0.0048	CcSEcCtD
Rilpivirine—Nervous system disorder—Capecitabine—colon cancer	0.000179	0.00477	CcSEcCtD
Rilpivirine—CYP2B6—liver—colon cancer	0.000179	0.0166	CbGeAlD
Rilpivirine—Diarrhoea—Fluorouracil—colon cancer	0.000179	0.00476	CcSEcCtD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—TYMS—colon cancer	0.000179	0.0145	CbGpPWpGaD
Rilpivirine—Vomiting—Vincristine—colon cancer	0.000178	0.00474	CcSEcCtD
Rilpivirine—Skin disorder—Capecitabine—colon cancer	0.000178	0.00472	CcSEcCtD
Rilpivirine—Rash—Vincristine—colon cancer	0.000177	0.0047	CcSEcCtD
Rilpivirine—Dermatitis—Vincristine—colon cancer	0.000177	0.0047	CcSEcCtD
Rilpivirine—Headache—Vincristine—colon cancer	0.000176	0.00467	CcSEcCtD
Rilpivirine—Vomiting—Irinotecan—colon cancer	0.000174	0.00462	CcSEcCtD
Rilpivirine—Immune system disorder—Methotrexate—colon cancer	0.000173	0.0046	CcSEcCtD
Rilpivirine—Dizziness—Fluorouracil—colon cancer	0.000173	0.0046	CcSEcCtD
Rilpivirine—Rash—Irinotecan—colon cancer	0.000172	0.00458	CcSEcCtD
Rilpivirine—Dermatitis—Irinotecan—colon cancer	0.000172	0.00458	CcSEcCtD
Rilpivirine—Headache—Irinotecan—colon cancer	0.000171	0.00455	CcSEcCtD
Rilpivirine—CYP1A2—Metapathway biotransformation—CHST4—colon cancer	0.000171	0.0138	CbGpPWpGaD
Rilpivirine—ABCB1—epithelium—colon cancer	0.000169	0.0156	CbGeAlD
Rilpivirine—Mental disorder—Methotrexate—colon cancer	0.000168	0.00446	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000168	0.0135	CbGpPWpGaD
Rilpivirine—Malnutrition—Methotrexate—colon cancer	0.000167	0.00443	CcSEcCtD
Rilpivirine—Nausea—Vincristine—colon cancer	0.000167	0.00443	CcSEcCtD
Rilpivirine—Vomiting—Fluorouracil—colon cancer	0.000166	0.00442	CcSEcCtD
Rilpivirine—Insomnia—Capecitabine—colon cancer	0.000165	0.0044	CcSEcCtD
Rilpivirine—Rash—Fluorouracil—colon cancer	0.000165	0.00439	CcSEcCtD
Rilpivirine—Dermatitis—Fluorouracil—colon cancer	0.000165	0.00438	CcSEcCtD
Rilpivirine—Headache—Fluorouracil—colon cancer	0.000164	0.00436	CcSEcCtD
Rilpivirine—Nausea—Irinotecan—colon cancer	0.000162	0.00431	CcSEcCtD
Rilpivirine—Decreased appetite—Capecitabine—colon cancer	0.000159	0.00423	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000158	0.0042	CcSEcCtD
Rilpivirine—Fatigue—Capecitabine—colon cancer	0.000158	0.00419	CcSEcCtD
Rilpivirine—ABCB1—renal system—colon cancer	0.000157	0.0145	CbGeAlD
Rilpivirine—Nausea—Fluorouracil—colon cancer	0.000155	0.00413	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Capecitabine—colon cancer	0.00015	0.00398	CcSEcCtD
Rilpivirine—ABCG2—lymph node—colon cancer	0.000149	0.0138	CbGeAlD
Rilpivirine—Abdominal pain—Capecitabine—colon cancer	0.000145	0.00384	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000141	0.00375	CcSEcCtD
Rilpivirine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000137	0.0111	CbGpPWpGaD
Rilpivirine—CYP3A4—liver—colon cancer	0.000135	0.0125	CbGeAlD
Rilpivirine—Infection—Methotrexate—colon cancer	0.000135	0.0036	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—colon cancer	0.000134	0.00355	CcSEcCtD
Rilpivirine—CYP2B6—Metapathway biotransformation—CHST5—colon cancer	0.000133	0.0107	CbGpPWpGaD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—colon cancer	0.000133	0.0107	CbGpPWpGaD
Rilpivirine—Skin disorder—Methotrexate—colon cancer	0.000132	0.00352	CcSEcCtD
Rilpivirine—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000132	0.0106	CbGpPWpGaD
Rilpivirine—Asthenia—Capecitabine—colon cancer	0.000131	0.00349	CcSEcCtD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00013	0.0105	CbGpPWpGaD
Rilpivirine—ABCB1—lymphoid tissue—colon cancer	0.00013	0.012	CbGeAlD
Rilpivirine—ABCB1—digestive system—colon cancer	0.000129	0.0119	CbGeAlD
Rilpivirine—Diarrhoea—Capecitabine—colon cancer	0.000125	0.00333	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—colon cancer	0.000123	0.00327	CcSEcCtD
Rilpivirine—Somnolence—Methotrexate—colon cancer	0.000121	0.00322	CcSEcCtD
Rilpivirine—Dizziness—Capecitabine—colon cancer	0.000121	0.00321	CcSEcCtD
Rilpivirine—ABCB1—bone marrow—colon cancer	0.000118	0.011	CbGeAlD
Rilpivirine—Decreased appetite—Methotrexate—colon cancer	0.000118	0.00315	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000118	0.00312	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—colon cancer	0.000117	0.00312	CcSEcCtD
Rilpivirine—Vomiting—Capecitabine—colon cancer	0.000116	0.00309	CcSEcCtD
Rilpivirine—Rash—Capecitabine—colon cancer	0.000115	0.00307	CcSEcCtD
Rilpivirine—Dermatitis—Capecitabine—colon cancer	0.000115	0.00306	CcSEcCtD
Rilpivirine—Headache—Capecitabine—colon cancer	0.000115	0.00305	CcSEcCtD
Rilpivirine—ABCB1—vagina—colon cancer	0.000113	0.0105	CbGeAlD
Rilpivirine—Gastrointestinal pain—Methotrexate—colon cancer	0.000111	0.00296	CcSEcCtD
Rilpivirine—Nausea—Capecitabine—colon cancer	0.000109	0.00289	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—colon cancer	0.000108	0.00286	CcSEcCtD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.000105	0.00845	CbGpPWpGaD
Rilpivirine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000103	0.00835	CbGpPWpGaD
Rilpivirine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000103	0.00833	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—HNF4A—colon cancer	0.000103	0.00828	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	0.000101	0.00812	CbGpPWpGaD
Rilpivirine—Asthenia—Methotrexate—colon cancer	9.77e-05	0.0026	CcSEcCtD
Rilpivirine—ABCB1—liver—colon cancer	9.57e-05	0.00885	CbGeAlD
Rilpivirine—Diarrhoea—Methotrexate—colon cancer	9.31e-05	0.00248	CcSEcCtD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	9.08e-05	0.00733	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	9.07e-05	0.00732	CbGpPWpGaD
Rilpivirine—Dizziness—Methotrexate—colon cancer	9e-05	0.00239	CcSEcCtD
Rilpivirine—CYP3A4—Irinotecan Pathway—APC—colon cancer	8.69e-05	0.00702	CbGpPWpGaD
Rilpivirine—Vomiting—Methotrexate—colon cancer	8.66e-05	0.0023	CcSEcCtD
Rilpivirine—Rash—Methotrexate—colon cancer	8.58e-05	0.00228	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—colon cancer	8.58e-05	0.00228	CcSEcCtD
Rilpivirine—Headache—Methotrexate—colon cancer	8.53e-05	0.00227	CcSEcCtD
Rilpivirine—SLCO1B3—Metabolism—CA7—colon cancer	8.35e-05	0.00674	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	8.1e-05	0.00654	CbGpPWpGaD
Rilpivirine—Nausea—Methotrexate—colon cancer	8.09e-05	0.00215	CcSEcCtD
Rilpivirine—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	7.84e-05	0.00633	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	7.68e-05	0.0062	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	7.67e-05	0.00619	CbGpPWpGaD
Rilpivirine—ABCB1—lymph node—colon cancer	7.34e-05	0.00679	CbGeAlD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	6.75e-05	0.00545	CbGpPWpGaD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.7e-05	0.0054	CbGpPWpGaD
Rilpivirine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.22e-05	0.00502	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	6.05e-05	0.00488	CbGpPWpGaD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	5.94e-05	0.00479	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	5.93e-05	0.00479	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	5.71e-05	0.00461	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CA7—colon cancer	5.61e-05	0.00453	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.34e-05	0.00431	CbGpPWpGaD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	5.27e-05	0.00425	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CA7—colon cancer	5.2e-05	0.0042	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CHST5—colon cancer	5.06e-05	0.00409	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ODC1—colon cancer	5.06e-05	0.00409	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—HNF4A—colon cancer	4.94e-05	0.00399	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	4.77e-05	0.00385	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	4.61e-05	0.00372	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	4.51e-05	0.00364	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—PPARG—colon cancer	4.45e-05	0.0036	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.13e-05	0.00333	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	3.96e-05	0.0032	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	3.88e-05	0.00313	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CA7—colon cancer	3.81e-05	0.00308	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CHST5—colon cancer	3.4e-05	0.00275	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ODC1—colon cancer	3.4e-05	0.00275	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	3.3e-05	0.00267	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CHST5—colon cancer	3.15e-05	0.00254	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ODC1—colon cancer	3.15e-05	0.00254	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	3.1e-05	0.0025	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	3.09e-05	0.00249	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	2.89e-05	0.00233	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.88e-05	0.00232	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CA7—colon cancer	2.88e-05	0.00232	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	2.86e-05	0.00231	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.85e-05	0.0023	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CA7—colon cancer	2.81e-05	0.00227	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	2.75e-05	0.00222	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	2.75e-05	0.00222	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	2.67e-05	0.00216	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	2.67e-05	0.00216	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	2.6e-05	0.0021	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.58e-05	0.00208	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	2.57e-05	0.00207	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—MYC—colon cancer	2.54e-05	0.00205	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CASP3—colon cancer	2.49e-05	0.00201	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.44e-05	0.00197	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	2.39e-05	0.00193	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	2.39e-05	0.00193	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.38e-05	0.00192	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	2.34e-05	0.00189	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	2.34e-05	0.00189	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ODC1—colon cancer	2.31e-05	0.00186	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CHST5—colon cancer	2.31e-05	0.00186	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.29e-05	0.00185	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CA7—colon cancer	2.24e-05	0.00181	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	2.21e-05	0.00178	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PPARG—colon cancer	2.14e-05	0.00173	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.11e-05	0.00171	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.09e-05	0.00169	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.94e-05	0.00157	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.92e-05	0.00155	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.88e-05	0.00152	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.78e-05	0.00143	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CHST5—colon cancer	1.74e-05	0.00141	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ODC1—colon cancer	1.74e-05	0.00141	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.74e-05	0.00141	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CA7—colon cancer	1.73e-05	0.0014	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CHST5—colon cancer	1.7e-05	0.00137	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ODC1—colon cancer	1.7e-05	0.00137	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.64e-05	0.00133	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.56e-05	0.00126	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.4e-05	0.00113	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.37e-05	0.0011	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CHST5—colon cancer	1.36e-05	0.0011	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ODC1—colon cancer	1.36e-05	0.0011	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ABCB1—colon cancer	1.34e-05	0.00108	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.32e-05	0.00107	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—TYMS—colon cancer	1.31e-05	0.00106	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.23e-05	0.000992	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MYC—colon cancer	1.22e-05	0.000987	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.2e-05	0.000966	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.18e-05	0.000956	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.16e-05	0.000934	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.1e-05	0.000892	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.1e-05	0.000889	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.07e-05	0.000864	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CHST5—colon cancer	1.05e-05	0.000847	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ODC1—colon cancer	1.05e-05	0.000847	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.04e-05	0.000842	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.01e-05	0.000816	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.6e-06	0.000775	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.57e-06	0.000773	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	9.39e-06	0.000758	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PPARG—colon cancer	9.31e-06	0.000751	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.19e-06	0.000742	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ABCB1—colon cancer	8.99e-06	0.000725	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	8.87e-06	0.000716	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TYMS—colon cancer	8.83e-06	0.000713	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—AKT1—colon cancer	8.48e-06	0.000684	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ABCB1—colon cancer	8.32e-06	0.000672	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TYMS—colon cancer	8.17e-06	0.00066	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	8.15e-06	0.000658	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	7.88e-06	0.000636	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—colon cancer	7.32e-06	0.000591	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.2e-06	0.000581	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.8e-06	0.000549	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.65e-06	0.000537	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARG—colon cancer	6.25e-06	0.000505	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ABCB1—colon cancer	6.1e-06	0.000492	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—EP300—colon cancer	6.09e-06	0.000492	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TYMS—colon cancer	5.99e-06	0.000484	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARG—colon cancer	5.79e-06	0.000467	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.66e-06	0.000457	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.61e-06	0.000453	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—colon cancer	4.92e-06	0.000397	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.71e-06	0.00038	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCB1—colon cancer	4.61e-06	0.000372	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—colon cancer	4.55e-06	0.000368	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TYMS—colon cancer	4.53e-06	0.000365	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CA—colon cancer	4.5e-06	0.000364	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TYMS—colon cancer	4.42e-06	0.000357	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.41e-06	0.000356	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARG—colon cancer	4.24e-06	0.000343	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—EP300—colon cancer	4.09e-06	0.00033	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—EP300—colon cancer	3.79e-06	0.000306	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—colon cancer	3.68e-06	0.000297	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.67e-06	0.000296	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCB1—colon cancer	3.59e-06	0.00029	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TYMS—colon cancer	3.53e-06	0.000285	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.49e-06	0.000281	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—colon cancer	3.34e-06	0.000269	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARG—colon cancer	3.21e-06	0.000259	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARG—colon cancer	3.13e-06	0.000253	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CA—colon cancer	3.03e-06	0.000244	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CA—colon cancer	2.8e-06	0.000226	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—EP300—colon cancer	2.78e-06	0.000224	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCB1—colon cancer	2.77e-06	0.000224	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TYMS—colon cancer	2.72e-06	0.00022	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.72e-06	0.000219	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—colon cancer	2.52e-06	0.000204	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARG—colon cancer	2.5e-06	0.000202	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—colon cancer	2.47e-06	0.0002	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—colon cancer	2.46e-06	0.000199	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—colon cancer	2.29e-06	0.000185	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—EP300—colon cancer	2.1e-06	0.000169	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CA—colon cancer	2.05e-06	0.000166	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—EP300—colon cancer	2.05e-06	0.000165	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—colon cancer	1.97e-06	0.000159	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARG—colon cancer	1.93e-06	0.000156	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—colon cancer	1.68e-06	0.000135	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—EP300—colon cancer	1.63e-06	0.000132	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CA—colon cancer	1.55e-06	0.000125	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—colon cancer	1.52e-06	0.000122	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CA—colon cancer	1.51e-06	0.000122	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—colon cancer	1.27e-06	0.000102	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—EP300—colon cancer	1.26e-06	0.000102	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—colon cancer	1.24e-06	9.99e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CA—colon cancer	1.21e-06	9.76e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—colon cancer	9.88e-07	7.98e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CA—colon cancer	9.33e-07	7.53e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—colon cancer	7.62e-07	6.16e-05	CbGpPWpGaD
